Kalorama Information’s “Cell Culture: The World Market for Media, Sera and Reagents, 3rd. Edition” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 10/04/2011 -- Several cell culture-derived biopharmaceutical drugs were launched in the US and European markets in 2010. Biopharmaceuticals (recombinant proteins, monoclonal antibody and nucleic acid-based products) represent the fastest growing sector in the pharmaceutical industry. Driving the extraordinary interest in biopharmaceuticals is the ability of these large proteins to target diseases in a very specific manner, thus maximizing efficacy while minimizing side effects.

Growth in the development and production of biopharmaceuticals is the most significant driver of the cell culture market. Biological products are developed from large and complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. Protein-based biopharmaceuticals are invariably produced by an initial cell culture step (upstream processing), followed by product recovery, purification and formulation into final product format (downstream processing).

This report analyzes the world market for the cell cultures used in these steps and the major trends driving this market. Forecasts and current market sizing are provided in three specific segments:

• Media,

• Sera, and

• Reagents

In addition to a thorough discussion of the technologies and techniques currently employed and emerging in the cell culture area, the Kalorama's exhaustive report provides specific information on:

• Market Size, growth, and forecasts of the segments through 2015

• Competitive Market Share by leading supplier as of 2010.

• Estimated Market Share by Region (North America, Europe, U.S.)

• Key Market Drivers and Restraints for suppliers, including discussions of biopharmaceutical pipelines, biomedical R&D directions, and the future of transgenic plant and animal production.

• Review of the various expression systems (Bacteria, Yeast, Insect, and Mammal) and the biopharmaceutical product manufactured by these systems

• Discussion of the preferences in media types vying for dominance in the market, including the following:

ADCF - animal derived component free media
CD - chemically defined media
CSFM - complete serum free medium
PF - protein free media
SF - serum free media
SFM - serum free medium

• Major Trends Impacting the Market stem cell research (including plans of major companies)cell culture-based vaccine Production and generic bipharmaceuticals

• Profiles of Leading Suppliers and information about M&A activities in recent years

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company and cell culture supply company representatives included marketing directors, division managers, and product representatives.

All Kalorama reports advertise the single user price, which limits access to one user. We also feature department and global pricing for reports that will be utilized by more than one user at your company. Please ask your sales representative or select the correct license on our website.

http://www.reportsnreports.com/reports/130897-cell-culture-the-world-market-for-media-sera-and-reagents-3rd.html

Browse All: http://www.reportsnreports.com/market-research/biotechnology/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Kalorama Information’s “Wireless Opportunities in Healthcare 2011 (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies)” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 09/22/2011 -- In previous editions of Kalroama Information's wireless technologies market report, we described wireless IT systems and devices being used in some model healthcare environments.

The use of these technologies has moved well beyond these settings and should be of interest to marketers of many products, even those outside of healthcare IT. While not every healthcare system has gone wireless, 2011 has seen no letdown in the implementation of these technologies in healthcare. Almost all healthcare organizations have had to adjust to the use of these technologies in some form.

Kalorama's Wireless in Healthcare 2011 is your guide to the growing market for wireless healthcare applications in the United States. This report contains explanations that cut through the confusion surrounding technologies and provide readers with a total picture of wireless in healthcare.

Current and Future US Markets for Bluetooth, Zigbee, RFID, UWB, WMAN and WLAN.

Since the previous edition, some technologies have performed better than others and 2010 results have led to reforecasting of some technologies. The competitive arena has not dramatically changed since last year, with a few key players dominating and opportunity for smaller companies, but developments have been interesting.

The report provides:

• Discussion of Trends in the Wireless Technology in Healthcare Marketplace, Products and Customer Case Studies of Wireless Applications.
• Current Revenues and Forecasts to 2015 for all Wireless Technologies by Healthcare Application.
• Current Revenues and Forecasts to 2015 for all Wireless Technologies by Technology Type.
• Scores of Tables and Figures provide accessible information about the wireless in healthcare marketplace.
• Detailed Profiles of 9 Key Companies in this market, major products and key executives.
• Explanation of the Major Technologies, ( Zigbee, Bluetooth, RFID, UWB, WMAN and WLAN )that are being used in healthcare.

Because of the focus on healthcare IT in the United States, the report focuses on this region. Some discussion of non-US opportunities and company efforts is included. The report provides today's market figures and realistic projections for future revenues based on consideration of data and extensive interviews with industry experts. Looking at several detailed case studies, the report shows how wireless is already being used by major healthcare companies across a wide variety of applications, including:

• Hospitals
• Homecare and Telemedicine
• Pharmaceutical Research (Clinical Drug Trials)
• Inventory Control
• Pharmaceutical Sales Force Management
• Inventory Control
• Physician Offices
• Nursing Homes
• Medical and Diagnostic Laboratories
• Patient Monitoring

Case Studies
The report looks at several case studies where wireless technologies were implemented at various healthcare concerns and assesses the benefits derived from implementaton. Some case studies include:

• Sentara Healthcare's Electronic Medical Records and Wireless Technologies Information Technology System
• Rural Wireless Healthcare: 3G Mobile Medicine Partners in 3G Mobile Medicine Project
• George Washington University Hospital - WLAN Implementation
• Meridian At Home Pilot Program, Benefits of Implementation
• Memorial Medical Center - WLAN Implementation Requirement for Implementation of Wireless Technologies
• Cardinal Health and RFID Implementation
• Achieve Healthcare Technologies - e-Prescription
• Bayer Healthcare - e-Drug Trials and Requirement for e-Drug Trials

The report details the companies in this field - and why there is still an opportunity for new competitors. It discusses the currently implemented technologies and the technologies to watch that in four years, will gain impressive market share. Finally, it describes the trends that will push market expansion and reduction of cost of these devices. The healthcare applications and marketplace for the following technologies are discussed in detail:

• Bluetooth,
• Zigbee,
• RFID
• UWB
• Wireless Local Area Networks (WLAN)
• Wireless Metropolitan Area Networks (WMAN)
• Wireless Wide Area Networks (WWAN)

As a global report, Wireless Opportunities in Healthcare will look at opportunities available in the European Union and at Asian markets, while focusing on the US market
Kalorama's unique and thorough research process provides an exhaustive analysis of this evolving market. Information was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. For the purpose of this study, Kalorama Information conducted telephone and email interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with wireless technology company representatives included marketing directors, division managers, and product development representatives.

In addition to superior coverage of the overall wireless healthcare market, in-depth company profiles are included for the following wireless technology companies:

• Allscripts Healthcare Solutions, inc.
• Cerner Corporation
• Cisco Systems, Inc.
• Extreme Networks, Inc.
• GE Healthcare
• Hewlett Packard Corporation
• McKesson Corporation
• Medtronic, Inc.
• Motorola Solutions, Inc.
• Philips Healthcare
• Siemens Healthcare

http://www.reportsnreports.com/reports/125591-wireless-opportunities-in-healthcare-2011-the-market-for-bluetoo.html

Browse All: http://www.reportsnreports.com/market-research/healthcare/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Kalorama Information’s “Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations) Pre-Publication” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 09/22/2011 -- Because of their ability to deliver fast results at the point of care, rapid testing is a focus area of healthcare providers and payors in infectious disease prevention. The decentralized testing market is experiencing growth faster than the diagnostic markets at large and over the long term will create opportunities for innovative companies.

Kalorama Information has been reporting on the rapid test area for several years and has identified the segments with fastest growth, and infectious disease has surfaced as one of those segments. This report, Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations), examines this segment, and especially new threats for which there are large markets in the developing world and in developed countries.

An Opportunity For Test Makers
Infectious disease is a broad category, and in some disease areas, diagnostic companies already own market share. Increasingly hospitals and clinics are seeing new infectious disease threats and tests are being developed to assist them. Within the infectious disease testing market, this report details the opportunities that could be found when diseases of the developing world enter the healthcare system of the developed. This report provides market projections for point of care diagnostics in the developed and developing world for the following infectious diseases:

* Chagas Disease, Rapid Test Market Forecast to 2016
* Chikungunya, Rapid Test Market Forecast to 2016
* Dengue Fever, Rapid Test Market Forecast to 2016
* HIV, Rapid Test Market Current Size and Forecast to 2016
* HPV, Rapid Test Market Current Size and Forecast to 2016
* Leishmaniasis, Rapid Test Market Forecast to 2016
* Onchocerciasis (River Blindness), Rapid Test Market Forecast to 2016
* STDs, Rapid Test Market Current Size and Forecast to 2016
* Tuberculosis, Rapid Test Market Forecast to 2016

In addition the report also provides:
* The Overall Point of Care Diagnostics Market
* Economics of Financial and International Programs
* Company Profiles of Leaders in the POC Infectious Disease Market
* EMR and Connectivity Issues
* Tests in Development
* The Role of Drug Resistance
* Disease Statistics

Technical and Market Considerations
Many reports provide market projections, but those projections rely on the development of new tests which will enter the market. This report considers the technical factors behind product development. Tests for diseases can only be provided where the technical means to develop a test exist. This report also deals with the technical choices, possibilities and limitations to today's tests. Reagent issues, testing on strips, instrumented and non-instrumented tests. These factors will impact the tests that reach the market.

http://www.reportsnreports.com/reports/125590-point-of-care-diagnostics-for-emerging-infectious-disease-threats.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Kalorama Information’s “The World Market for Cancer Therapeutics and Biotherapeutics, 4th Edition (Pre-Publication)” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 09/21/2011 -- This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics, 4th Edition - focuses on several segments for cancer treatment including:

• Chemotherapy, including -subcategories Alkylating Agents, Antimetabolites, Cytotoxic Agents, Plant Derivatives -Brands such as Elotaxin, Taxotere, Gemzar, Alimta and Temodar with Market Share for each

• Hormone Therapy: -Subcategories include Corticosteroids, Hormone Agonists/Antagonists, Aromatase Inhibitors and SERMS-Brands such as Arimidex, Casodex, Zoladex, Femara and Lupron with Market Share for each.

• Immunotherapy and Biotherapy, including: -Monoclonal antibodies, interleukins/interferons, vaccines and other biotherapy-Brands such as Rituxan, Herceptin, Gleevec, Evastin and Erbitux

One of the most promising new approaches in modern cancer treatment is immunotherapy or biotherapy, the development of methods to augment and enhance the body's natural tendency to defend itself against malignant tumors without damaging healthy tissue. The report devotes particular attention to these new therapies.

This report, Kalorama's fourth complete research effort into the oncology treatments market in the past ten years, provides market size information for the various types of cancers including the following:

• Bladder
• Breast
• Cervical
• Colorectal
• Esophageal
• Head/Neck
• Kidney
• Leukemia
• Liver
• Lung
• Lymphoma
• Melanoma
• Multiple Myeloma
• Neuroblastoma
• Ovarian
• Pancreatic
• Prostate
• Stomach

The report covers both currently marketed and late stage development cancer products. Revenues for each current market segment were generated using dollar and unit sales for each product.

The report includes statistical information for cancers by type worldwide, with special emphasis on the U.S. market. Specifically, cancers where there are current products available or are in development and/or have significant incidence/mortality rates are profiled. The market segments provide an overview, description of products on the market, leading product sales, market estimates and forecasts, and competitive analysis of leading providers. The report also includes a list of products in development and current issues and trends affecting the industry.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.

As part of its coverage, the report looks at the following trends
• Insurance and Reimbursement Issues
• Cancer Drug Costs
• Personalized Medicine
• Targeted Cancer Therapy
• Pharmacogenomics
• Alliances Acquisitions and Licensing Agreements
• Patient-Reported Outcomes
• Alcohol's Affect on Cancer Incidence
• Healthy Lifestyles Continue to Show Promise for Cancer Prevention
• Obesity in the U.S.
• Outlook for a Healthier U.S. Population
• Cancer Trends
• Marketing and Distribution Trends
• Geographical Trends (US, Europe, Japan)
• Elderly Clinical Trial Involvement
• Late-Stage Drug Development Trends
All market data pertains to the world market at the manufacturers' level. The base year for data was 2010. Historical data was provided for the years 2005 through 2009, with forecast data provided for 2011 through 2015. Compound annual growth rates (CAGRs) are provided for the 2005-2010, 2010-2015 and 2005-2015 periods for each industry segment covered. Competitive analysis is provided for the year 2010. The forecasted market analysis for 2010-2015 was based on probability of approval and sales of products in late stage development, competitive trends, product marketing, and demographic trends.

http://www.reportsnreports.com/reports/125589-the-world-market-for-cancer-therapeutics-and-biotherapeutics-4th.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Kalorama Information’s “Remote and Wireless Patient Monitoring Markets” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 09/14/2011 -- Advanced patient monitoring systems that provide wireless or remote patient monitoring to share data outside the immediate patient care area continue to see sales growth. Features on these devices can range from basic remote tracking ability to "face-to-face" interaction between clinicians and patients or even data sorting of the vast amount of data collected in order to put it into the context of a patient's condition. Many systems now transfer data to an electronic medical record (EMR), and some come with full-service outsourcing.

This Kalorama Information report, Remote & Wireless Patient Monitoring Markets covers three product areas: wireless and remote patient monitors, patient data processing applications and equipment, and EMR data transfer equipment and applications, which coordinate the flow of data to hospital electronic medical record system. Data is provided for the US market in 2010 and forecasted to 2015.

There are four primary markets for these new technologies, which are as follows:
• Hospitals;
• Home healthcare;
• Nursing homes; and
• Other (including first responders, institutional, physician offices, and military)

In addition to providing market sizes by venue serviced, the report also breaks out the market for remote and wireless patient monitoring based on the disease category being monitored by these devices for the following categories:
• Asthma Monitoring
• COPD Monitoring
• CHF Monitoring
• CHD Monitoring
• Cancer Monitoring
• Diabetes Monitoring
• Other Disease Monitoring
Patient data processing applications and equipment use algorithms to evaluate monitoring measurements for a patient's specific condition(s). Usually, these can be customized by the physician, with reports sent to the physician. In the market for high-tech patient monitoring systems, the applications and equipment are either integrated into the patient monitoring system or are add-ons to the measuring systems. As with data processing, EMR data transfer equipment and applications for this report are either components of, or add-ons to, patient monitoring systems. This report does not include EMR applications.

Most players in the market are discussed as part of Kalorama's competitive analysis of the remote patient monitoring market. As part of our coverage of the marketplace for remote and wireless systems, several major manufacturers are profiled in detail in this report This report was constructed using both a primary and secondary research approach. Annual reports, trade publications and other sources were thoroughly researched, but interviews were conducted among industry executives were used to make assessments of markets and to discover trends and construct forecasts.

http://www.reportsnreports.com/reports/125275-remote-and-wireless-patient-monitoring-markets.html

Browse All: http://www.reportsnreports.com/market-research/semiconductor-and-electronics/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Kalorama Information’s “Out of Pocket Healthcare Spending 2011” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 08/16/2011 -- The costs of health care products and services continue to rise briskly, significantly outpacing currently low inflation rates. According to the U.S. Department of Labor, the average household's spending on health care after inflation has been rising by about 1.4% each year. Retirees have been particularly hard hit, with inflation-adjusted out-of-pocket costs rising by more than 2% each year as a result of increased spending on prescription drugs.

While insurance is the most common form of payment for healthcare services, increasingly customers are paying for their own expenses. Pharmaceutical, device and diagnostic companies, should recognize that a part of their revenues are originating directly or indirectly from out of pocket expenditures. Unique financial services have been created to facilitate non-insurance-paid health care services, and more are expected to be created in the near term.

This report, Out of Pocket Healthcare 2011 focuses on those costs of health care which are not paid for by government or private insurance. Once a small percentage of costs of the health care system, the percentage borne by the consumer is increasing steadily. Included in the report is:
• Estimates of the Current 'Out of Pocket' Healthcare Spending Market and Forecasts to 2015.
• Breakdown of Spending by Type (Elective, Hospital, Emergency Room, Dental, Vision Outpatient, Prescription Drugs, Office Based Visit, Other)
• Health Care Reform and Its Impact on Out of Pocket Spending
• Statistics For the Types of Consumers Most Likely to Pay Out of Pocket
• Drivers of the Out of Pocket Trend and Potential Limiters
• Overview of the U.S. Healthcare System, Insured and Uninsured Population.
• The Types of Services and Products Purchased with Out of Pocket dollars
• Overview of the growing Healthcare Finance market and a look at key competitors.

The economic recession of December 2007 to October 2009 represented a major downturn that led to broad-based cost-cutting, rising unemployment and reduced disposable income. The impact of the pullback - which some experts compared to the Great Depression of 1929 to 1934 - cannot be overstated. Kalorama Information looks at what change has resulted in out of pocket expenditure for healthcare as a result of the recession and weak recovery.

As part of Kalorama Information's trusted process, secondary research from government, medical and industry sources was utilized along with interviews with industry experts in the healthcare finance industry.

In Weak Recovery, Consumers Bearing More of Healthcare Costs

Healthcare costs paid out-of-pocket by consumers have increased steadily in recent years, but according to Kalorama Information, the recession and weak recovery are additional drivers for the trend. In fact, the independent healthcare market research firm has found in its new report, Out of Pocket Healthcare Spending 2011, that out-of-pocket healthcare spending was $303 billion in 2010 and the rate of growth will accelerate at 8% annually in the coming years.

According to the U.S. Department of Labor, the average household's inflation-adjusted spending on healthcare has been rising by about 1.4% each year. Retirees have been particularly hard hit, with inflation-adjusted out-of-pocket healthcare costs rising by more than 2% each year as a result of increased spending on prescription drugs.

"The recent recession brought with it a high unemployment rate, exacerbated by increased outsourcing of jobs to lower cost countries, broad-based cost-cutting and reduced disposable income," said Bruce Carlson, publisher of Kalorama Information. "Meanwhile, affordable healthcare has become less available but more necessary."

The costs of healthcare products and services continue to rise briskly; in some cases, they have become astronomical. For example, in 2010, average annual healthcare premiums for a family of four ($13,770) approached annual earnings at the federal minimum wage ($14,500). As a result, Kalorama notes that managed care organizations are increasingly shifting the burden of healthcare costs to consumers by way of increased co-pays and premiums.

About 70% of consumers' out-of-pocket healthcare spending goes to premiums. And this is increasing as HMOs and employers engage in cost shifting. Co-pays make up a little over 3% of spending, which Kalorama also expects to increase due to cost shifting. Another 27% of out-of-pocket spending goes to direct payments.

The Health Care Reform of 2010 has significantly changed the landscape of the U.S. healthcare industry by extending healthcare coverage to approximately 32 million previously uninsured people. Although this could potentially decrease some demand for out-of-pocket spending from the previously uninsured, it may in fact, raise awareness of the value of basic care and bring more persons into the medical system, thus potentially increasing spending as newly insured consumers take a renewed interest in their health and wellness.

http://www.reportsnreports.com/reports/75938-out-of-pocket-healthcare-spending-2011.html

Browse All: http://www.reportsnreports.com/market-research/healthcare/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Kalorama Information’s “Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 08/08/2011 -- A hospital-acquired infection (HAI)is a new infection that develops in a patient during hospitalization. It is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, so infections incubating, but not clinically apparent, at admission are excluded. This type of infection is also known as a nosocomial infection (or more generically healthcare-associated infections).

The following market data is provided in this report:
• Hospital-Acquired Infections Diagnostics Market
• Forecast for HAI Diagnostics to 2015
• HAI Tests on the Market
• Market for Diagnostics by Infection Type (C. Diff., MRSA, Pneumonia, Other)
• Molecular HAI Market vs. Conventional HAI Market, Present and in 2015
• Geographic Breakdown of Testing (U.S., Europe, Asia, ROW)
• New Hospital Infection Product Testing Products in the Market
• Company Profiles
• Treatment Products on the Market, HAI Antibiotic market Size and Forecast

http://www.reportsnreports.com/reports/117996-hospital-acquired-infections-diagnostic-markets-and-testing-deve.html

Both diagnostics and treatment segments have unique circumstances for growth which are discussed in detail in the report. Worldwide, both segments combined are worth more than $9 billion for 2010 with 2015 sales expected to reach $10.3 billion. The market has shown an increase of 3% annually with sales increasing from $7.9 billion in 2005. Although the treatment segment will continue to struggle to maintain growth, the testing segment will offset declines beginning in 2012.

Browse All: http://www.reportsnreports.com/market-research/biotechnology/

This report primarily focuses on bacterial nosocomial infections with some mention of viral infections. The major consideration is given to bacterial nosocomial infections because a) they are the most frequent type of infections spread in the hospital setting, and b) the practical aspects of diagnosis and therapy are more meaningful based both on medical considerations and on market considerations.

Some of the issues discussed in this report include:
• Development of Potential Life-Saving Products
• Development of Fast Testing Systems
• Growing Drug Resistance
• Development of Better Pharmacodiagnostics
• Market Opportunity and Growth Rates Expected in Diagnostics versus Treatment
• Hospital Procedures for Use of Testing and Antibiotics
• Attention to Special Population Issues
• Demographics and Epidemiology
• New Government Guidelines and Requirements for Preventing Infection
• Focus on Alliances and Partnerships

Market analysis in this report considers primarily the epidemiological considerations and the size of patient groups both in the United States and globally, where available. We have accumulated the most recent data available, understanding that virtually no organization does extensive studies on these applications on a regular basis. Many studies are highly localized and may only apply to a community, state or country (more often countries that are not a part of the major markets for nosocomial diagnostic and therapeutic products). In many instances, we have had to draw from broader epidemiologic data, that is, on data that reach outside of the hospital environment in order to try and construct a picture of the nosocomial testing and treatment needs.

The primary focus of this report is on the bacterial form of nosocomial infections, and those with significant impact on the hospital setting and markets. In looking at these infections, we consider the diagnostic and therapeutic technologies that are currently available and attempt to project trends in these product areas. To some extent, we are limited by the activity of the industries associated with the diagnosis and treatment of these infections. For the most part, these activities are limited and the advanced technologies seen in other areas of medical application are not necessarily present in terms of microbiology.

The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including microbiologists, pathologists, hospital authorities, research scientists, business development managers and marketing managers.

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Kalorama Information’s “Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 08/05/2011 -- The high growth rates and successful launch of several products recently has kept interest in the global vaccine market high. The global market for vaccines experienced strong growth through 2010 and this is expected to continue through the forecast period. Growth is being fueled by new product introductions and rising usage in all regions.

Kalorama Information has been closely following vaccine markets and since 2003 has instituted a yearly market research report schedule to keep up with fast-moving developments. Our latest comprehensive update, Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry, examines the market for vaccines used in humans for various disease. This state-of-the-industry report is a must-have for any executive who wants to stay on top of a rapidly changing market and see what's expected based on analysis of major company pipelines.

Trends are discussed in this report including the introduction of needle-free systems and the production of vaccines, as well as product safety, supply shortages, and the use of vaccines to prevent pandemics and address bioterrorism, and innovations in vaccine delivery systems. News and reports of vaccine-related illness tend to exacerbate the public's fears and result in higher rates of non-immunization, and these are discussed in this edition of the report.

The report covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable.

Included in this report are current market size and forecast for the following vaccines:

Pediatric Vaccines:
• Combinations
• Hepatitis
• HIB
• MMR
• Pneumococcal
• Poliovirus
• Varicella
• Other Pediatric

Adult Vaccines:
• Cervical Cancer
• Hepatitis
• Influenza
• Pneumococcal
• Travel; DT; Misc.

Important trends such as vaccine safety, vaccine shortages, preventing pandemics, vaccines and bioterrorism, DNA vaccination, innovations in vaccine delivery systems and innovations in vaccine Production are covered in the report.

Kalorama has expanded the global perspective of this report in this edition, including estimates of vaccine sales (pediatric and adult segments) in the following regions:
• U.S.
• Rest of North Amer.
• South America
• Europe
• Japan
• India
• China
• Rest of World
In addition, the report profiles key competitors in the vaccine industry. Companies profiled in the report include:
• AlphaVax, Inc.
• Bavarian Nordic A/S
• Baxter Healthcare
• Bharat Biotech
• Celldex Therapeutics
• Crucell / Johnson and Johnson
• Emergent biosolutions
• GlaxoSmithKline
• Medimmune
• Merck & Co. Inc
• Nabi Biopharmaceuticals
• Novartis
• Pfizer
• Sanofi Pasteur

Revenue estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for the historic 2005 to 2009 period and forecasts are provided through 2014. Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts' reports and other sources. Interviews with company representatives and other experts were conducted to capture the perspectives from industry participants' point of view and assess trends... these form the basis of the forecasting and competitive analysis.

http://www.reportsnreports.com/reports/117997-vaccines-2011-world-market-analysis-key-players-and-critical-t.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Kalorama Information’s “World Market for Dialysis Equipment and Services” is now available at ReportsnReports.com.

Dallas, TX -- (SBWIRE) -- 08/05/2011 -- This report looks at both the equipment and service aspects of the dialysis industry. The industry enjoys a unique place in the healthcare sector. The industry encompasses two very lucrative segments -- the medical device industry (dialysis products and supplies segment) and the healthcare services industry (dialysis services segment).

The dialysis industry remains a robust, multi-billion dollar business that has managed to fuel its growth engine in the past 5 years. What makes this market more interesting and challenging is its relatively small customer base - a bit under two million dialysis patients form its entire universe. It is the high value of these customers that make this a competitive industry.
• Detailed Forecasts to 2015
• In-Depth Profiles of the Competitive Companies in Dialysis Treatment, Equipment and Supplies.
• Scores of Figures and Tables featuring useful data, demographic and market trends that can be used to supplement internal memos or presentation.
• Detailed World Dialysis Market Review including specific reviews of the dialysis service, equipment and supplies market in the United States, Japan, UK, Italy, India, China and Australia and Canada.
• Market Share of Major Care and Equipment Providers.
• The Changing Regulatory Environment.
• Detailed Patient Demographics Current Data, Forecasts and Trends.

Kalorama's trusted information-gathering process provides most accurate study of the kidney dialysis market available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies and in the kidney dialysis and equipment industry. While major research literature and government information is culled, key market insights originate from interviews with industry leaders.

There are several key issues and trends impacting the future of the dialysis market. Demographics, insurance and reimbursement issues, and consolidation in the industry will continue to influence the outcome of the market in the future. Issues and trends explored in this study include:

• Prevalence of Diabetes in Developing Regions
• Increasing Life Expectancy Worldwide
• Hospital Admissions for Infection
• Insurance and Reimbursement Issues
• Access to Care for Native Populations
• Kidney Transplantation
• Product Development and Innovation
• Consolidation and Joint Ventures in the Industry
• Home Dialysis
• Heat Disinfection for Water Quality
• Dialysis Treatment Comfort
• National Salt Reduction Initiative

http://www.reportsnreports.com/reports/200-world-market-for-dialysis-equipment-and-services.html

Browse All: http://www.reportsnreports.com/market-research/medical-devices/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689

Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: +1-888-989-8004
E-mail: sales@reportsnreports.com
http://www.reportsnreports.com
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Kalorama Information’s “Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccine and Biologics” is now available at ReportsnReports.com.

Dallas,, TX -- (SBWIRE) -- 08/04/2011 -- The line between drug delivery and drug substance will continue to become more elusive in the near future as shown in the analysis in this report, as researchers work to improve drug properties through drug design and molecular modeling. Consequently, in the next decade, drug delivery technologies will be a focal point of competition within the pharmaceutical industry.

This Kalorama Information report, Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccine and Biologics takes a look at this aspect of the pharmaceutical marketplace with figures and forecasts for pharmaceutical companies and the companies that supply technology to them. The success of specific drugs will be tied to innovative delivery techniques, which will enable the targeting that will exploit the clinical properties of a new generation of drugs.

The needle-free drug delivery market is growing rapidly. The development of better delivery systems in conjunction with the discovery of novel pharmacological compounds will lead to significant improvements in drug delivery. This report looks at that trend and reports current and forecasted revenues for the injectable drug delivery market, segmented into two main categories:

• Needle-Free Products Market (Including Drug and Technology)
• Needle-Free Products Market (Technology Only)

This breakout makes the report relevant to business plans of either device technology companies or pharmaceutical concerns. The report also includes information that will be of assistance to business planners:
• Trends in the Vaccine Market
• Market Size and Forecast for Needle-Free Vaccine Technology
• Trends in Biopharmaceuticals
• Leading Pharmaceutical Product Sold With Needle-Free Technologies
• Products in Development
• Detailed Profiles of Key Companies in Needle-Free Technologies.
• Current Market Size and Forecasts to 2013
• Needle-Free Cost Savings, Autojets, Health Care Reform, and Other Trends and Developments

Companies Profiled in the report include:
• Alkermes, Inc.
• ALZA Corp.
• Antares Pharma, Inc.
• Bioject Medical Technologies, Inc.
• CyDex, Inc.
• MGI Pharma, Inc
• Nektar Therapeutics
• Pacira Pharmaceuticals, Inc.
• pSivida
• SurModics, Inc
• Zogenix Corporation
• AP Pharma
• Baxter BioPharma Solutions
• QLT USA, Inc
• Ypsomed Holding AG

The research conducted by Kalorama included comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. New technologies, market developments, and research and development trends and expenditures were identified through patent and database searches, as well as via interviews with key personnel. Person-to-person, email and telephone interviews were the primary method of gathering information.

http://www.reportsnreports.com/reports/117995-needle-free-drug-delivery-the-market-for-alternatives-to-needle-.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689
Blog: http://www.reportsnreportsblog.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm